A rapid review of evidence and recommendations from the SIOPE radiation oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic or other crises.

Published on Jul 1, 2020in Radiotherapy and Oncology4.856
· DOI :10.1016/J.RADONC.2020.04.035
Geert O. Janssens17
Estimated H-index: 17
,
H. Mandeville1
Estimated H-index: 1
(ICR: Institute of Cancer Research)
+ 11 AuthorsTom Boterberg31
Estimated H-index: 31
(Ghent University Hospital)
Sources
Abstract
OBJECTIVE: To derive evidence-based recommendations for the optimal utilisation of resources during unexpected shortage of radiotherapy capacity. METHODS AND MATERIALS: We have undertaken a rapid review of published literature on the role of radiotherapy in the multimodality treatment of paediatric cancers governing the European practice of paediatric radiotherapy. The derived data has been discussed with expert paediatric radiation oncologists to derive a hierarchy of recommendations. RESULTS: The general recommendations to mitigate the potential detriment of an unexpected shortage of radiotherapy facilities include: (1) maintain current standards of care as long as possible (2) refer to another specialist paediatric radiotherapy department with similar level of expertise (3) prioritise use of existing radiotherapy resources to treat patients with tumours where radiotherapy has the most effect on clinical outcome (4) use chemotherapy to defer the start of radiotherapy where timing of radiotherapy is not expected to be detrimental (5) active surveillance for low-grade tumours if appropriate and (6) consider iso-effective hypofractionated radiotherapy regimens only for selected patients with predicted poor prognosis. The effectiveness of radiotherapy and recommendations for prioritisation of its use for common and challenging paediatric tumours are discussed. CONCLUSION: This review provides evidence-based treatment recommendations during unexpected shortage of paediatric radiotherapy facilities. It has wider applications for the optimal utilization of facilities, to improve clinical outcome in low- and middle-income countries, where limited resources continue to be a challenge.
📖 Papers frequently viewed together
6 Citations
3 Citations
112 Citations
References64
Newest
#1Michael C. Frühwald (Boston Children's Hospital)H-Index: 34
#2Martin Hasselblatt (Boston Children's Hospital)H-Index: 1
Last. N Graf (DKFZ: German Cancer Research Center)H-Index: 4
view all 41 authors...
BACKGROUND: Controversy exists as to what may be defined as standard of care (including markers for stratification) for patients with Atypical Teratoid Rhabdoid Tumors (ATRT). The European Rhabdoid Registry, EU-RHAB, recruits uniformly treated patients and offers standardized genetic and DNA methylation analyses. METHODS: Clinical, genetic and treatment data of 143 patients from 13 European countries were analyzed (2009 - 2017). Therapy consisted of surgery, anthracycline-based induction and eit...
24 CitationsSource
#1Andrea Riccardo Filippi (UNIPV: University of Pavia)H-Index: 29
#2Elvio G. RussiH-Index: 27
Last. Renzo Corvò (Health Science University)H-Index: 28
view all 4 authors...
89 CitationsSource
#1E. Chandy (The Royal Marsden NHS Foundation Trust)H-Index: 1
#2H. Taylor (The Royal Marsden NHS Foundation Trust)H-Index: 4
Last. Henry Mandeville (The Royal Marsden NHS Foundation Trust)H-Index: 14
view all 15 authors...
Abstract Aims Cancer remains a leading cause of death in children and adolescents in the developed world. Despite advances in oncological management, rates of primary treatment failure remain significant. Radiation of recurrent or metastatic disease improves survival in adults but there is little data to support clinical decision making in the paediatric/teenage and young adult population. Materials and methods We present a retrospective case series of 14 patients treated with stereotactic ablat...
5 CitationsSource
#1Andrea FerrariH-Index: 63
#2Johannes H. M. Merks (Boston Children's Hospital)H-Index: 26
Last. Michela CasanovaH-Index: 57
view all 19 authors...
PURPOSE: We analysed the cohort of paediatric patients with metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated in the BERNIE protocol, i.e. open-label, multicentre, randomised phase II study evaluating the role of bevacizumab (BO20924/ITCC-006; ClinicalTrials.gov: NCT00643565). METHODS: Eligible patients were randomised 1:1 to add or not add bevacizumab to nine courses of intensive multi-drug chemotherapy, followed by 12-month maintenance chemotherapy (plus surgery and radiothe...
4 CitationsSource
#1Benoit You (UCBL: Claude Bernard University Lyon 1)H-Index: 30
#2Alain RavaudH-Index: 77
Last. Jean Pierre Lotz (University of Paris)H-Index: 10
view all 11 authors...
101 CitationsSource
#1Nirmal Kandel (WHO: World Health Organization)H-Index: 5
#2Stella Chungong (WHO: World Health Organization)H-Index: 9
Last. Jun Xing (WHO: World Health Organization)H-Index: 2
view all 4 authors...
Summary Background Public health measures to prevent, detect, and respond to events are essential to control public health risks, including infectious disease outbreaks, as highlighted in the International Health Regulations (IHR). In light of the outbreak of 2019 novel coronavirus disease (COVID-19), we aimed to review existing health security capacities against public health risks and events. Methods We used 18 indicators from the IHR State Party Annual Reporting (SPAR) tool and associated dat...
228 CitationsSource
#1Rishi S. Kotecha (UWA: University of Western Australia)H-Index: 12
49 CitationsSource
#1Samantha M. Buszek (University of Texas MD Anderson Cancer Center)H-Index: 4
#2Karine A. Al Feghali (University of Texas MD Anderson Cancer Center)H-Index: 3
Last. Caroline Chung (University of Texas MD Anderson Cancer Center)H-Index: 11
view all 6 authors...
Treatment for glioblastoma (GBM) includes surgical resection and adjuvant radiotherapy (RT) and chemotherapy. The optimal time interval between surgery and RT remains unclear. The National Cancer Database (NCDB) was queried for patients with GBM. Overall survival (OS) was estimated using Kaplan-Meier and log-rank tests. Univariate (UVA) and multivariable Cox regression (MVA) modeling was used to determine predictors of OS. A total of 45,942 patients were included. On MVA: younger age, female gen...
8 CitationsSource
Abstract Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of...
14.1k CitationsSource
#1Ruth Ladenstein (Boston Children's Hospital)H-Index: 53
#2Ulrike Pötschger (Community College of Rhode Island)H-Index: 43
Last. Holger N. Lode (Greifswald University Hospital)H-Index: 20
view all 24 authors...
To explore the effects of immunotherapy in the International Society of Paediatric Oncology Europe Neuroblastoma Group SIOPEN high-risk neuroblastoma 1 trial (HR-NBL1 trial), two cohorts were studied: one prior to and one after the introduction of dinutuximab beta. All patients received standard induction and high-dose therapy (HDT) with autologous stem cell rescue (ASCR); the local control comprised surgery and radiotherapy to the primary tumour site, followed by isotretinoin. A landmark timepo...
26 CitationsSource
Cited By10
Newest
#1Daniel C. Moreira (St. Jude Children's Research Hospital)H-Index: 8
Source
#1Zahra Siavashpour (Shahid Beheshti University of Medical Sciences and Health Services)H-Index: 6
Last. Mosayyeb Mobasheri (TMU: Tarbiat Modares University)
view all 3 authors...
Treatment management of cancer patients in the radiation oncology departments during the current COVID-19 pandemic is challenging. A systematic review of published consensus/guidelines on the role of radiotherapy prioritization, suggested treatment protocols, and set up management was undertaken based on the PRISMA protocol and through PubMed/PMC, Scopus, Google Scholar, Web of Science databases until 01/20/2021. One hundred and sixty-eight publications or regional consensus were included. Summa...
Source
#1Daniel C. Moreira (St. Jude Children's Research Hospital)H-Index: 8
#2Gerard C Millen (University of Birmingham)H-Index: 1
Last. Douglas S. Hawkins (Fred Hutchinson Cancer Research Center)H-Index: 55
view all 5 authors...
The COVID-19 pandemic has considerably changed health services for children with cancer worldwide by creating barriers throughout the care continuum. Reports available at this time suggest that asymptomatic and mild upper and lower respiratory tract syndromes are the most common presentation of COVID-19 in children with cancer. Nonetheless, severe cases of COVID-19 and deaths secondary to the infection have been reported. In addition to the direct effects of the severe acute respiratory syndrome...
Source
#1Daniel C. Moreira (St. Jude Children's Research Hospital)H-Index: 8
#2Elizabeth Sniderman (St. Jude Children's Research Hospital)H-Index: 2
Last. Carlos Rodriguez-Galindo (St. Jude Children's Research Hospital)H-Index: 61
view all 25 authors...
The COVID-19 pandemic quickly led to an abundance of publications and recommendations, despite a paucity of information on how COVID-19 affects children with cancer. This created a dire need for a trusted resource with curated information and a space for the pediatric oncology community to share experiences. The Global COVID-19 Observatory and Resource Center for Childhood Cancer was developed, launched, and maintained by the International Society of Pediatric Oncology and St. Jude Children's Re...
3 CitationsSource
#1Patrick J Horsley (RNSH: Royal North Shore Hospital)H-Index: 3
#2Michael BackH-Index: 23
Last. Thomas EadeH-Index: 27
view all 6 authors...
The COVID-19 pandemic will present a range of challenges to radiation oncology departments. Early data suggest that cancer patients carry a higher than average, but still low absolute risk of hospitalization from COVID-19. The risk of severe events for those who are hospitalized however, is high. Resources for usual cancer care will likely be limited. Decisions to alter, delay or omit treatment during this period should consider both the risk of the cancer and of COVID-19 to the patient, as well...
1 CitationsSource
#1David J Thomson (University of Manchester)H-Index: 11
#2Sue S. Yom (UCSF: University of California, San Francisco)H-Index: 40
Last. Christopher Estes (Mercy Medical Center (Baltimore, Maryland))H-Index: 2
view all 23 authors...
Purpose Numerous publications during the COVID-19 pandemic recommended the use of hypofractionated radiation therapy. This project assessed aggregate changes in the quality of the evidence supporting these schedules to establish a comprehensive evidence base for future reference and highlight aspects for future study. Methods and Materials Based on a systematic review of published recommendations related to dose fractionation during the COVID-19 pandemic, 20 expert panelists assigned to 14 disea...
11 CitationsSource
#1Puneet Pareek (AIIMS: All India Institute of Medical Sciences)H-Index: 6
#2Jeewan Ram Vishnoi (AIIMS: All India Institute of Medical Sciences)H-Index: 6
Last. Sanjeev Misra (AIIMS: All India Institute of Medical Sciences)H-Index: 20
view all 5 authors...
The core pillars of multimodal care of patients with cancer are surgical, radiation, and medical oncology. The global pandemic of coronavirus disease 2019 (COVID-19) has suddenly resurrected a new pillar in oncology care: teleoncology. With oncologists reaching out to patients through telemedicine, it is possible to evaluate and fulfill patients' needs; triage patients for elective procedures; screen them for influenza-like illness; provide them with guidance for hospital visits, if needed; and ...
12 CitationsSource
#1P.J. Lewis (Royal College of Radiologists)H-Index: 2
#2T. Roques (Royal College of Radiologists)H-Index: 1
6 CitationsSource
#1Weiping Wang (Peking Union Medical College Hospital)H-Index: 8
#2Ke Hu (Peking Union Medical College Hospital)H-Index: 11
Last. Fuquan Zhang (Peking Union Medical College Hospital)H-Index: 10
view all 4 authors...
The daily new confirmed Coronavirus disease 2019 (COVID-19) cases have decreased in some European and Asian countries. Many countries and areas have started to ease public restrictions. Here, we share our experiences and recommendations on how to conduct radiotherapy after public restrictions have eased or upon reopening. Firstly, COVID-19 nucleic acid test screening should be performed for all new admitted patients in areas with enough test capability. Secondly, radiotherapy can be conducted re...
1 CitationsSource
#1Rao Khan (WashU: Washington University in St. Louis)H-Index: 13
#2Arash Darafsheh (WashU: Washington University in St. Louis)H-Index: 18
view all 5 authors...
Abstract As the COVID-19 spread continues to challenge the societal and professional norms, radiotherapy around the globe is pushed into an unprecedented transformation. We will discuss how clinical physics has transformed to ascertain safety and quality standards across four facilities around the world through diversity of action, innovation, and scientific flexibility.
5 CitationsSource